AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• The market in Asia-Pacific is expected to grow at a higher CAGR during the forecast period driven by lower implementation costs, supportive government policies and rapidly expanding pharmaceutical sector

  80% confidence

• The present market environment consists of approximately 130 participants including major, large, medium, and small enterprises

  80% confidence

• Nearly 80% of firms are implementing machine learning to digitize various phases of the drug manufacturing process

  80% confidence

• Over 95% of the companies involved in AI for drug production provide advanced software solutions

  80% confidence

• The global AI in pharma manufacturing market size is estimated to grow from USD 1.20 billion in the current year to USD 34.7 billion by 2040, at a CAGR of 28% during the forecast period

  80% confidence

• North America captures the majority of the market currently and this trend is unlikely to change in the future

  80% confidence

• More than 60% of major pharmaceutical companies are utilizing AI to revolutionize their manufacturing processes

  80% confidence

Cited in these Via News reports

• Big Tech AI Models Force Specialized Language Startups to Close as Investors Flee →
• Big Tech AI Releases Trigger Investor Flight from Small Language Model Startups Globally →